![Christopher McAleer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher McAleer worked as Chief Scientist at Hesperos, Inc. and as Chief Scientific Officer at AIM ImmunoTech, Inc. from 2022 to 2024.
Dr. McAleer completed undergraduate studies at West Chester University of Pennsylvania and earned graduate and doctorate degrees from the University of Central Florida.
| Sociétés | Poste | Fin |
|---|---|---|
| AIM IMMUNOTECH INC. | Directeur Technique/Scientifique/R&D | 01/02/2024 |
Hesperos, Inc.
 Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Manufactures drugs and medicines | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
AIM ImmunoTech, Inc.
 AIM ImmunoTech, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical drugs | Health Technology |
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Chester University of Pennsylvania
 West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hesperos, Inc.
Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Manufactures drugs and medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
